 |
|
|
|
|
|
|
| Article 1 to 10 out of 14 concerning UCB Pharma S.A.
|
-
UCB transfers UK-based medicinal chemistry program to BioFocus DPI
(13 Aug 2008)
Galapagos NV announced that its service division BioFocus DPI and UCB have signed a contract for the provision of chemistry services in the UK by BioFocus DPI, for one of UCB's medicinal chemistry programs. The total contract value for Galapagos ...
-
Pierre Fabre acquires Over-The-Counter Business of UCB in France, Benelux, Switzerland and Greece
(10 Jan 2007)
Pierre Fabre and UCB jointly announce that Pierre Fabre has acquired the OTC business of UCB in France, Benelux, Switzerland and Greece. The acquisition involves certain mature products with strong brand names (a.o. Carbolevure, Revitalose, ...
-
Successful takevoer of Schwarz Pharma by UCB
(05 Jan 2007)
UCB announces that it has received tenders amounting to 87.62% of the total outstanding share capital of SCHWARZ PHARMA AG (or 86.80% of the fully diluted share capital, including treasury shares) during its tender offer for SCHWARZ PHARMA which ...
-
New CEO of SCHWARZ PHARMA joins executive commitee of UCB
(15 Dec 2006)
UCB appointed Detlef Thielgen, SCHWARZ PHARMA's new Chief Executive Officer, to UCB's Executive Committee effective January 1, 2007.In his career with SCHWARZ PHARMA AG, Detlef Thielgen has held several positions in finance and controlling, ...
-
Significant acceptances by SCHWARZ shareholders for UCB tender offer
(13 Dec 2006)
The final total of acceptances received by midnight on Friday December 8 will be available on Thursday December 14, 2006. Acceptances already counted show UCB has received tenders in excess of 76% of the fully diluted share capital of SCHWARZ ...
-
UCB Obtains European Antitrust Clearance for Take-Over of SCHWARZ PHARMA
(23 Nov 2006)
UCB announced that the EU Commission has cleared the proposed take-over of SCHWARZ PHARMA by UCB. As announced on November 10, 2006, the U.S. Federal Trade Commission (FTC) has allowed the waiting period to expire without expressing any concerns. ...
-
UCB Expands to Canada
(09 Nov 2006)
Under the auspices of the 2006 Belgian Economic Trade Mission to Canada, H.R.H. Prince Philippe of Belgium officially inaugurated UCB Pharma Canada at a ceremony held in Toronto. On this occasion UCB Pharma Canada shared its plans for growth in ...
-
Schwarz Pharma AG: business combination agreement with UCB
(26 Sep 2006)
Takeover offer for Schwarz Pharma
SCHWARZ PHARMA AG on the one hand, and UCB SA, Brussels as well as its wholly owned indirect subsidiary UCB SP GmbH (together 'UCB'), on the other hand, have entered into a business combination agreement. According to the terms of the business ...
-
UCB sells to Adams Respiratory Therapeutics Delsym cough surpressants
(29 May 2006)
UCB S.A. announces that it has reached an agreement with Adams Respiratory Therapeutics Inc. to sell DelsymŽ (dextromethorphan polistirex), an over-the-counter (OTC) 12-hour liquid cough suppressant. In addition, the two companies have entered into ...
-
UCB transfers back to Recordati the rights for the sale of Corifeo(R) (Lercanidipine) in Germany
(26 Apr 2006)
UCB announced that it has reached an agreement with Recordati to transfer back the sales and marketing rights in Germany of CorifeoŽ, an antihypertensive calcium channel blocker, for a payment to UCB of 10 million euros."This transaction is another ...
|
|
|
|
|
Top